Mitchell J. Frederick

11.6k citations

80 papers · 3.3k · h-index 32

Impact in

Otorhinolaryngology top 1%
- Head and Neck Cancer Studies
Oncology top 2%
- Cancer-related Molecular Pathways
- Chemokine receptors and signaling

Papers in

Molecular Biology 39
- RNA modifications and cancer 13
- Cancer-related gene regulation 6
- Epigenetics and DNA Methylation 5
Oncology 25
- Cancer-related Molecular Pathways 16
- Chemokine receptors and signaling 5

Co-authors: Gary L. Clayman (20 shared papers)Ying C. Henderson (15 shared papers)Adel K. El‐Naggar (13 shared papers)Jeffrey N. Myers (33 shared papers)Curtis R. Pickering (29 shared papers)Arumugam Jayakumar (8 shared papers)Mary Wang (5 shared papers)Kenji Mitsudo (5 shared papers)
Journals: Clinical Cancer Research (11 papers)Cancer Research (11 papers)Molecular Cancer Therapeutics (4 papers)Journal of Clinical Oncology (4 papers)Head & Neck (4 papers)
Partner nations: United States Japan Australia

In The Last Decade

Mitchell J. Frederick

77 papers receiving 3.2k citations

Peers

Countries citing papers authored by Mitchell J. Frederick

Since Specialization

Citations

This map shows the geographic impact of Mitchell J. Frederick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell J. Frederick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell J. Frederick more than expected).

Fields of papers citing papers by Mitchell J. Frederick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell J. Frederick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell J. Frederick. The network helps show where Mitchell J. Frederick may publish in the future.

Co-authors

The 25 scholars most cited alongside Mitchell J. Frederick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mitchell J. Frederick Line = papers co-authored together Mitchell J. Frederick links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. Journal of Clinical Oncology ·Gary L. Clayman, Adel K. El‐Naggar, Scott M. Lippman, Ying C. Henderson, Mitchell J. Frederick, James A. Merritt, Louis A. Zumstein, Therese M. Timmons, T.-J. Liu, Lawrence E. Ginsberg, Jack A. Roth, Waun Ki Hong, Patricia A. Bruso, Helmuth Goepfert	1998	285
2	Randomized, Double-Blind Comparison of Once-Weekly Dalbavancin versus Twice-Daily Linezolid Therapy for the Treatment of Complicated Skin and Skin Structure Infections Clinical Infectious Diseases ·L. E. Jauregui, S. Babazadeh, Elyse Seltzer, L. Goldberg, Dainis Krieviņš, Mitchell J. Frederick, David Krause, I. Satilovs, Žilvinas Endzinas, J. Breaux, W. O'Riordan	2005	249
3	BRAK/CXCL14 Is a Potent Inhibitor of Angiogenesis and a Chemotactic Factor for Immature Dendritic Cells Cancer Research ·Thomas D. Shellenberger, Mary Wang, Manu Gujrati, Arumugam Jayakumar, Robert M. Strieter, Marie D. Burdick, Constantin G. Ioannides, Clayton L. Efferson, Adel K. El‐Naggar, Dianna Roberts, Gary L. Clayman, Mitchell J. Frederick	2004	207
4	CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth Proceedings of the National Academy of Sciences ·Martin Augsten, Christina Hägglöf, Eleonor Olsson, Claudia Stolz, Panagiotis Tsagozis, Tetyana Levchenko, Mitchell J. Frederick, Åke Borg, Patrick Micke, Lars Egevad, Arne Östman	2009	198
5	In Vivo Expression of the Novel CXC Chemokine BRAK in Normal and Cancerous Human Tissue American Journal Of Pathology ·Mitchell J. Frederick, Ying C. Henderson, Xiaochun Xu, Michael T. Deavers, Aysegul A. Sahin, Hong Wu, Dorothy E. Lewis, Adel K. El‐Naggar, Gary L. Clayman	2000	154
6	Intratumoral Myeloid Cells Regulate Responsiveness and Resistance to Antiangiogenic Therapy Cell Reports ·Lee B. Rivera, David Meyronet, Valérie Hervieu, Mitchell J. Frederick, Emily K. Bergsland, Gabriele Bergers	2015	124
7	Squamous Cell Carcinoma of the Oral Tongue in Young Non-Smokers Is Genomically Similar to Tumors in Older Smokers Clinical Cancer Research ·Curtis R. Pickering, Jiexin Zhang, David M. Neskey, Mei Zhao, Samar A. Jasser, Jiping Wang, Alexandra M. Ward, C. Jillian Tsai, Marcus V. Ortega Alves, Jane H. Zhou, Jennifer Drummond, Adel K. El‐Naggar, Richard A. Gibbs, John N. Weinstein, David A. Wheeler, Jing Wang, Mitchell J. Frederick, Jeffrey N. Myers	2014	118
8	Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells Cancer ·Vlad C. Sandulache, Thomas J. Ow, Curtis R. Pickering, Mitchell J. Frederick, Ge Zhou, Izabela Fokt, Melinda Davis‐Malesevich, Waldemar Priebe, Jeffrey N. Myers	2011	111
9	Key tumor suppressor genes inactivated by “greater promoter” methylation and somatic mutations in head and neck cancer Epigenetics ·Rafael Guerrero‐Preston, Christina Michailidi, Luigi Marchionni, (unknown), Mitchell J. Frederick, Jeffrey N. Myers, Srinivasan Yegnasubramanian, Tal Hadar, Maartje Noordhuis, Veronika Žižková, Elana J. Fertig, Nishant Agrawal, William H. Westra, Wayne M. Koch, Joseph A. Califano, Victor E. Velculescu, David Sidransky	2014	111
10	Chk1/2 Inhibition Overcomes the Cisplatin Resistance of Head and Neck Cancer Cells Secondary to the Loss of Functional p53 Molecular Cancer Therapeutics ·Mayur A. Gadhikar, Maria Rita Sciuto, Marcus V. Ortega Alves, Curtis R. Pickering, Abdullah A. Osman, David M. Neskey, Mei Zhao, Alison L. Fitzgerald, Jeffrey N. Myers, Mitchell J. Frederick	2013	98
11	Identification of 9 Genes Differentially Expressed in Head and Neck Squamous Cell Carcinoma Archives of Otolaryngology - Head and Neck Surgery ·Hernán González, Manu Gujrati, Mitchell J. Frederick, Ying C. Henderson, Arumugam Jayakumar, (unknown), Kenji Mitsudo, Hyung-Woo Kim, Gary L. Clayman	2003	95
12	Wee-1 Kinase Inhibition Overcomes Cisplatin Resistance Associated with High-Risk TP53 Mutations in Head and Neck Cancer through Mitotic Arrest Followed by Senescence Molecular Cancer Therapeutics ·Abdullah A. Osman, Marcus M. Monroe, Marcus V. Ortega Alves, Ameeta A. Patel, Panagiotis Katsonis, Alison L. Fitzgerald, David M. Neskey, Mitchell J. Frederick, Sang Hyeok Woo, Carlos Caulı́n, Teng‐Kuei Hsu, Thomas O. McDonald, Marek Kimmel, Raymond E. Meyn, Olivier Lichtarge, Jeffrey N. Myers	2014	91
13	Inhibition of Serine Proteinases Plasmin, Trypsin, Subtilisin A, Cathepsin G, and Elastase by LEKTI: A Kinetic Analysis Biochemistry ·Kenji Mitsudo, Arumugam Jayakumar, Ying C. Henderson, Mitchell J. Frederick, Ya’an Kang, Mary Wang, Adel K. El‐Naggar, Gary L. Clayman	2003	80
14	Potent and Broad-Spectrum Antimicrobial Activity of CXCL14 Suggests an Immediate Role in Skin Infections The Journal of Immunology ·Christa Maerki, Simone Meuter, Mark Liebi, Kathrin Mühlemann, Mitchell J. Frederick, Nikhil Yawalkar, Bernhard Moser, Marlene Wolf	2009	74
15	Targeted Therapy of VEGFR2 and EGFR Significantly Inhibits Growth of Anaplastic Thyroid Cancer in an Orthotopic Murine Model Clinical Cancer Research ·Maria K. Gule, Yunyun Chen, Daisuke Sano, Mitchell J. Frederick, Ge Zhou, Mei Zhao, Zvonimir L. Milas, Chad E. Galer, Ying C. Henderson, Samar A. Jasser, (unknown), James A. Bankson, Jeffrey N. Myers, Stephen Y. Lai	2011	68
16	MEK Inhibitor PD0325901 Significantly Reduces the Growth of Papillary Thyroid Carcinoma Cells In vitro and In vivo Molecular Cancer Therapeutics ·Ying C. Henderson, Yunyun Chen, Mitchell J. Frederick, Stephen Y. Lai, Gary L. Clayman	2010	65
17	New DNA Methylation Markers and Global DNA Hypomethylation Are Associated with Oral Cancer Development Cancer Prevention Research ·Jean‐Philippe Foy, Curtis R. Pickering, Vassiliki A. Papadimitrakopoulou, Jaroslav Jelı́nek, Steven H. Lin, William Nassib William, Mitchell J. Frederick, Jing Wang, Wenhua Lang, Lei Feng, Li Zhang, Edward S. Kim, You Hong Fan, Waun Ki Hong, Adel K. El‐Naggar, (unknown), Jeffrey N. Myers, Jean‐Pierre J. Issa, Scott M. Lippman, Li Mao, Pierre Saintigny	2015	59
18	NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma Cells ·Pooja A. Shah, Chenfei Huang, Qiuli Li, Sawad A. Kazi, Lauren A. Byers, Jing Wang, Faye M. Johnson, Mitchell J. Frederick	2020	58
19	Chemokines in cancer Expert Reviews in Molecular Medicine ·Mitchell J. Frederick, Gary L. Clayman	2001	56
20	Inhibition of the cysteine proteinases cathepsins K and L by the serpin headpin (SERPINB13): a kinetic analysis Archives of Biochemistry and Biophysics ·Arumugam Jayakumar, Ya’an Kang, Mitchell J. Frederick, Stephen C. Pak, Ying C. Henderson, Paula Holton, Kenji Mitsudo, Gary A. Silverman, Adel K. El‐Naggar, Dieter Brömme, Gary L. Clayman	2002	47

About Mitchell J. Frederick

Mitchell J. Frederick is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Cell Biology, having authored 80 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (16 papers), RNA modifications and cancer (13 papers), Cancer-related gene regulation (6 papers), Cell Adhesion Molecules Research (6 papers), Epigenetics and DNA Methylation (5 papers), Cancer-related molecular mechanisms research (5 papers), Protease and Inhibitor Mechanisms (5 papers) and Chemokine receptors and signaling (5 papers). The work is most often cited by research in Otorhinolaryngology (257 citations), Oncology (1.1k citations), Cancer Research (545 citations), Immunology (555 citations) and Immunology and Allergy (128 citations). Mitchell J. Frederick has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Gary L. Clayman, Ying C. Henderson, Adel K. El‐Naggar, Jeffrey N. Myers, Curtis R. Pickering, Arumugam Jayakumar, Mary Wang, Kenji Mitsudo, Mei Zhao and Vlad C. Sandulache. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Molecular Cancer Therapeutics, Journal of Clinical Oncology and Head & Neck.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mitchell J. Frederick

Impact in

Papers in i

In The Last Decade

Mitchell J. Frederick

Peers

Countries citing papers authored by Mitchell J. Frederick

Fields of papers citing papers by Mitchell J. Frederick

All Works

About Mitchell J. Frederick

Explore authors with similar magnitude of impact

Papers in